CDKN2C and neoplasm: For another cancer, Morishita et al. [47] demonstrated the association of p18 loss with poor prognosis in LIHC based on 51 samples; this may make sense, as p18 is known to arrest G0/G1 phase and thus CDKN2C presents a tumor suppressor gene for several cancers.